COMMUNIQUÉS West-GlobeNewswire

Unum Therapeutics to Present Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the American Society of Hematology (ASH) Summit on Emerging Immunotherapies for Hematological Diseases
12/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]
InMode Introduces Triton: The World’s First and Only Simultaneous Multi-Wavelength Hair Removal
12/07/2018
NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- InMode Ltd., a manufacturer and distributor of medical-aesthetic technology to doctors around the world, is pleased to announce the launch and FDA clearance of the Triton hair [...]
Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
12/07/2018
Primary Endpoint Achieved - Statistically Significant Convulsive Seizure Reduction for ZX008 versus Placebo for Adjunctive Treatment of Seizures ZX008 Also Demonstrated Statistical Significance in All Key Secondary [...]
Auxly Announces Director Resignation
12/07/2018
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") has announced today that following his appointment as Chief Executive Officer of a [...]
ViaDerma Provides an Update to Shareholders via a Letter from the CEO
12/07/2018
The Company is also in early stage discussions to sell its product on TV LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has posted a letter from [...]
Shire plc : Rule 2.9 Announcement
12/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 July 2018 Shire [...]
Saniona receives milestone payment from Boehringer Ingelheim
12/07/2018
PRESS RELEASE July 12, 2018 Saniona, a leading biotech company within ion-channel research, today announced that Boehringer Ingelheim has selected the first candidate for pre-clinical and clinical development under [...]
Genmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer Immunotherapies
12/07/2018
Company Announcement Genmab gains exclusive access to multiple novel proprietary tumor targets identified by Immatics Biotechnologies’ XPRESIDENT ® technology Creation of novel immuno-oncology drugs combining Genmab and [...]
Van Leeuwenhoeck Issues Equity Research Note Highlighting Addex Investment Opportunity
12/07/2018
Geneva, Switzerland, 12 July 2018 – Addex Therapeutics (SIX: ADXN) announced today that the independent life science research company Van Leeuwenhoeck has issued an equity research note highlighting the Addex investment [...]
HEXO Announces Stock Option Grants to Directors, Officers and Employees
12/07/2018
GATINEAU, Quebec, July 11, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation ("HEXO" or the "Company") (TSX:HEXO) announces that it has made a grant of stock options under its stock option plan to certain of its [...]
HEXO annonce l'octroi d'options d'achat d'actions à ses administrateurs, dirigeants et employés
12/07/2018
GATINEAU, Québec, 11 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) annonce qu'en vertu de son régime d'options d'achat d'actions, elle a accordé des options d'achat d' [...]
Assembly Biosciences Announces Pricing of $144 Million Offering of Common Stock
12/07/2018
INDIANAPOLIS and SAN FRANCISCO, July 11, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) (“Assembly”), today announced the pricing of an underwritten public offering of 4,000,000 shares of its common [...]
Sienna's BC Care Communities Awarded Accreditation with Exemplary Standing
11/07/2018
MARKHAM, Ontario, July 11, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna”) is pleased to announce that its eight residential care communities in British Columbia have once again been successfully [...]
BCLDB Selects Seven Oaks Branded Cannabis Products for Sale in British Columbia
11/07/2018
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- Seven Oaks is excited to announce its brand will be available in British Columbia through Beleave Kannabis Corp. who has been selected by the BC Liquor [...]
Natus Medical Announces Leadership Changes
11/07/2018
Jim Hawkins Retires after 14 years as President and CEO Jonathan Kennedy Appointed President and Chief Executive Officer Board Appoints Barbara Paul, M.D. Chairperson Releases Preliminary Q2 2018 Revenue and Conference [...]
Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME™ in the Treatment of Chronic Venous Leg Ulcers
11/07/2018
COLUMBIA, Md., July 11, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
11/07/2018
ALPHARETTA, Ga., July 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Integra LifeSciences to Host Second Quarter 2018 Earnings Results Conference Call on July 25, 2018
11/07/2018
PLAINSBORO, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release second quarter 2018 financial results on Wednesday, [...]
Ovid Therapeutics Announces Presentations Related to OV101 Fragile X Syndrome Program at the 16th National Fragile X Foundation (NFXF) International Conference
11/07/2018
CINCINNATI, July 11, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Pages